Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Virax Biolabs Group Ltd’s current trading price is -74.67% away from its 52-week high, while its distance from the 52-week low is 280.00%. The stock’s price range during this period has varied between $0.60 and $9.00. The company, active in the Healthcare sector, saw a trading volume of around 0.77 million for the day, considerably lower average daily volume of 6.0 million observed over the last three months.
Virax Biolabs Group Ltd’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $9.00 on 08/19/24, and the lowest price during the same period was recorded at $0.60 on 05/03/24.
How Financial Performance Impacts Market Capitalization
Virax Biolabs Group Ltd (VRAX) has experienced a quarterly rise of 79.53% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.90M and boasts a workforce of 17 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.09, with a change in price of +1.23. Similarly, Virax Biolabs Group Ltd recorded 4,801,960 in trading volume during the last 100 days, posting a change of +117.14%.
How VRAX’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for VRAX stands at 0.04. Similarly, the long-term debt-to-equity ratio is also 0.03.
VRAX Stock Stochastic Average
As of today, the raw stochastic average of Virax Biolabs Group Ltd over the past 50 days is 11.58%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 37.96%. Additionally, the Stochastic %K and %D values for the company were 46.14% and 41.28%, respectively, over the past 20 days.
VRAX Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a gain of 56.16%.However, over the last six months, we can see a weaker performance of 230.43%. Over the last 30 days, the price of VRAX has fallen by 18.13%. And in the last five days, it has surged by 49.02%.
